Phosphatidylinositol-3-OH kinase (PI(3)K) and the nutrient sensor mTOR are evolutionarily conserved regulators of cell metabolism. Here we show that PI(3)K and mTOR determined the repertoire of adhesion and chemokine receptors expressed by T lymphocytes. The key lymph node-homing receptors CD62L (L-selectin) and CCR7 were highly expressed on naive T lymphocytes but were downregulated after immune activation. CD62L downregulation occurred through ectodomain proteolysis and suppression of gene transcription. The p110d subunit of PI(3)K controlled CD62L proteolysis through mitogenactivated protein kinases, whereas control of CD62L transcription by p110d was mediated by mTOR through regulation of the transcription factor KLF2. PI(3)K-mTOR nutrient-sensing pathways also determined expression of the chemokine receptor CCR7 and regulated lymphocyte trafficking in vivo. Hence, lymphocytes use PI(3)K and mTOR to match metabolism and trafficking.
The lipid product of phosphoinositide-3-OH kinase (PI(3)K), phosphatidylinositol-(3,4,5)-triphosphate (PtdIns(3,4,5)P 3 ), binds to the pleckstrin homology domains of proteins and controls an array of signaling molecules, including serine or threonine kinases such as protein kinase B (PKB; also called Akt), Tec-family tyrosine kinases and guanine nucleotide-exchange proteins for Rac-and Rho-family GTPases 1 . T cell activation induces rapid and sustained production of PtdIns(3,4,5)P 3 in a response that is essential for T cell immune responses [2] [3] [4] . One important and evolutionarily conserved function of PI(3)K in T cells is to regulate cell metabolism and protein synthesis 5 . However, PI(3)K also regulates actin dynamics 6 and, accordingly, there has been a focus on the function of PI(3)K in regulating leukocyte motility and chemotaxis [7] [8] [9] [10] . The impetus for such studies came from the realization that the correct localization of lymphocytes is essential for effective immune responses. Thus, understanding the molecular mechanisms and signal-transduction pathways that control lymphocyte trafficking is important.
Naive T lymphocytes constantly circulate around the body through the blood, lymphatics and secondary lymphoid organs. Immune responses are initiated in secondary lymphoid organs, such as peripheral lymph nodes, when T cells encounter primed antigenpresenting cells expressing cognate antigen-major histocompatibility complexes together with the appropriate costimulatory molecules. Entry into lymph nodes requires the coordinated migration of cells and is dependent on chemokine receptors, such as CCR7, and molecules that mediate lymphocyte adhesion, such as CD62L (L-selectin) and integrins 11, 12 . T cells enter lymph nodes from the blood through specialized high endothelial venules. The first step of transmigration is CD62L-mediated tethering and rolling of naive lymphocytes on the endothelium of high endothelial venules 12, 13 . CD62L, which has high constitutive expression on naive and memory T lymphocytes 12 , is thus essential for the entry of these cells into peripheral lymph nodes 14, 15 .
Immune activation of T cells induces notable changes in their migratory patterns. Effector T lymphocytes migrate to a greater extent to nonlymphoid tissues and sites of inflammation and have less capacity to home to peripheral lymph nodes than do naive and memory T cells 12, 16 . Changes in the trafficking activity of T cells are important for immune responses and are mediated by changes in the expression of chemokine receptors and adhesion molecules. For example, activated T cells downregulate CCR7 and CD62L but upregulate expression of tissue-homing receptors such as the integrins VLA-4 and cutaneous lymphocyte-associated antigen 17 . CD62L expression at the membrane is controlled by a balance of two activities: the rate of transcription of the gene encoding CD62L, and the rate of CD62L proteolytic cleavage [18] [19] [20] . The proteolytic cleavage and shedding of CD62L from the cell surface of T lymphocytes is an immediate response to the triggering of antigen receptors 21 , whereas transcription of the gene encoding CD62L is lost after cytokinecontrolled differentiation of effector T cells 18, 22 . This transcriptional loss of CD62L is often used as a 'marker' to distinguish naive and antigen-experienced T cells in the blood and lymphoid organs during © 2008 Nature Publishing Group http://www.nature.com/natureimmunology immune responses. Effector and effector memory CD8 + cytotoxic T lymphocytes (CTLs) are CD62L lo and 'preferentially' home to peripheral tissues, whereas central memory T cells have high expression of CD62L similar to that of naive T cells and home to lymph nodes 12, 16 .
The signal-transduction pathways that dynamically modulate expression of CD62L and CCR7 during immune activation of T cells are not characterized. However, the different abilities of the cytokines interleukin 2 (IL-2) and IL-15 to downregulate CD62L expression in CD8 + T cells 23, 24 parallels the relative strength of these cytokines in stimulating PI(3)K-mediated cell growth responses 25 . Antigen-primed CD8 + T cells cultured in the presence of IL-2 thus sustain high PI(3)K signaling, synthesize large amounts of protein and downregulate CD62L. In contrast, T cells maintained with IL-15 can sustain only low PI(3)K signaling, synthesize less protein and fail to downregulate CD62L expression 24, 25 . Such data are purely correlative; however, the idea that PtdIns(3,4,5)P 3 abundance might control expression of T cell-homing receptors is intriguing because there is a large body of work that link PI(3)K to the control of lymphocyte metabolism, cell growth, chemotaxis and chemokinesis 7, 8, 10 . However, it has never been considered that PI(3)K might regulate lymphocyte recirculation by regulating plasma membrane expression of the lymph node-homing receptors CD62L and CCR7. Historically, loss of CD62L and CCR7 expression has been used to distinguish between naive and antigen-experienced T cells. Our study here shows that expression of CD62L and CCR7 instead 'reports' the PI(3)K and mTOR (A000094) signaling status of a T cell and is not simply an epigenetic consequence of immune activation. PtdIns(3,4,5)P 3 and mTOR signaling are thus essential determinants of the expression of CD62L and CCR7 and are key regulators of T cell migration in vivo.
RESULTS

PI(3)K regulates CD62L shedding
Triggering of the T cell antigen receptor (TCR) complex with complexes of cognate antigen and major histocompatibility complex induced rapid downregulation of CD62L from the membranes of naive T cells (Fig. 1a) . The initial acute loss of CD62L surface expression after immune activation of T cells is mediated mainly by proteolytic cleavage 21, 26 . Resting T cells showed basal constitutive cleavage of CD62L, but during immune activation, accelerated proteolysis occurred, resulting in more of the soluble cleavage product of CD62L in the culture supernatants of TCR-activated T cells (Fig. 1b) . The acute cleavage of CD62L takes place proximal to the cell membrane and is mediated by ADAM17 ('a disintegrin and metalloprotease 17'; also called TACE ('tumor necrosis factorconverting enzyme')) 27 . Substitution of the ADAM17 target sites in CD62L thus prevents CD62L shedding 21, 26 . To confirm the contribution of proteolytic cleavage of CD62L to TCR-mediated downregulation, we examined the ability of TCR triggering to downregulate the expression of a mutant of CD62L in which the membrane-proximal region of CD62L was replaced with that of P-selectin, thus removing the proteolytic target sequences for ADAM17. Crosslinking of TCR complexes with antibody to CD3 (anti-CD3) downregulated the expression of wild-type CD62L (Fig. 1c) . However, TCR triggering did not downregulate surface expression of CD62L molecules with mutant proteolytic target sequences (Fig. 1c) .
To test the involvement of PI(3)K in TCR-induced shedding of CD62L, we did experiments with LY294002, a pharmacological inhibitor of PI(3)K. LY294002 suppressed the shedding of CD62L induced by T cells activated with complexes of cognate peptide and major histocompatibility complex or crosslinking anti-CD3 (Fig. 1d) . Class 1 PI(3)K molecules have a p110 catalytic subunit and an adaptor regulatory subunit. There are four isoforms of p110 (p110a, p110b, p110g and p110d) and three adaptor subunits (p85a, p85b and p55g) 28 . In T cells, the p110d catalytic subunit of PI(3)K (A001770) produces the PtdIns(3,4,5)P 3 that is generated in response to TCR triggering 3, 29, 30 . We therefore examined CD62L regulation in T cells in which homologous recombination has been used to substitute wild-type p110d with a catalytically inactive mutant p110d (p110d(D910A)) 29 . Such T cells fail to produce PtdIns(3,4,5)P 3 in response to TCR triggering 3 to downregulate CD62L in response to TCR triggering (Fig. 1e) , although these cells shed CD62L in response to the pharmacological stimulus phorbol 12,13-dibutyrate, which bypasses the TCR.
CD62L transcription is suppressed by PI(3)K p110d
Low expression of CD62L in effector cytotoxic T cells reflects low gene transcription 22 . To investigate the involvement of PI (3) 23, 24 . CD8 + T cells cultured with IL-2 had low expression of CD62L, whereas cells cultured with IL-15 were CD62L hi (Fig. 2a) . These differences in CD62L expression reflected differences in the cellular abundance of CD62L mRNA, which was low in CTLs (Fig. 2b ). Yet CTLs did not globally downregulate all surface receptors. CTLs had high expression of CD25, the a-subunit of the IL-2 receptor, which reflected the abundant expression of CD25 mRNA in CTLs (data not shown). We found no evidence for more shedding of CD62L in IL-2-stimulated cells; instead, there was less CD62L proteolytic cleavage in T cells cultured with IL-2 than in those cultured with IL-15, which reflected the much lower synthesis of CD62L in IL-2-stimulated T cells (Fig. 2c) .
IL-2 and IL-15 differ in the strength of the PI(3)K signal they can induce 25 . Antigen-primed T cells maintained in IL-15 had a low cellular content of PtdIns(3,4,5)P 3 , at 1.2 Â 10 5 molecules per cell, compared with the 5.4 Â 10 5 molecules per cell in cells stimulated with IL-2, and had less activation of PI(3)K-mediated signaltransduction pathways ( Supplementary Fig. 1 online) . The ability of IL-2 to downregulate CD62L thus correlates with its ability to strongly activate PI(3)K signaling pathways. To probe the function of PI(3)K in the downregulation of CD62L by IL-2, we cultured antigenprimed T cells with IL-2 in the presence or absence of the PI(3)K inhibitor LY294002. Effector CD8 + T cells cultured with IL-2 had low expression of CD62L protein and mRNA, whereas effector T cells cultured in IL-2 plus LY294002 were CD62L hi and expressed abundant CD62L mRNA (Fig. 2d,e) . PI(3)K p110d is required for antigen receptor function but not for IL-2-induced proliferation of T cells 29, 30 . Hence, T cells expressing p110d(D910A) show attenuated proliferation in response to TCR stimulation; this can be overcome when they are activated through the TCR in the presence of strong costimulation provided by CD28 and in the presence of IL-2 (ref. 29) . CD8 + T cells expressing p110d(D910A) thus responded to IL-2 stimulation and proliferated exponentially over a period of 4 d when cultured in IL-2 to produce large granular cells indistinguishable from wild-type T lymphoblasts (Fig. 2f) . PI(3)K-PKB pathways regulate the expression of two key nutrient receptors in T cells: CD71 (the transferrin receptor) and CD98 (a critical component of L-type amino acid-transporter complexes) 25, 31 . The expression of CD71 and CD98 was similar on wild-type T cells and T cells expressing p110d(D910A) cultured in IL-2 ( Fig. 2g ). ( Fig. 2g) . These data showed a selective function for p110d in IL-2 signal transduction in that it is required for IL-2-mediated downregulation of CD62L but not for IL-2-induced expression of nutrient receptors, mitogenesis or cell growth. We obtained further evidence of the selective effect of p110d loss on CD62L expression in T cells by analyzing the expression of P-selectin and E-selectin ligands in IL-2-stimulated CD8 + T cells expressing p110d(D910A). Upregulation of P-selectin and E-selectin ligands normally accompanies the differentiation of effector T cells 12 . IL-2 stimulated CD8 + T cells expressing p110d(D910A) had high expression of P-selectin and E-selectin ligands equivalent to that of control CTLs (Fig. 2h) . Thus, p110d selectively controls the expression of L-selectin but not E-or P-selectin ligands in T cells.
Different PI(3)K pathways control CD62L expression TCR-stimulated T cells expressing p110d(D910A) have many signaling defects, including less activation of the mitogen-activated protein (MAP) kinases Erk1 and Erk2 (ref. 29) . That last defect could be relevant to the PI(3)K dependence of TCR-induced CD62L shedding, because chemokine-induced shedding of CD62L in neutrophils is mediated by Erk kinases 32 , which phosphorylate ADAM17 and control its trafficking to the cell surface [33] [34] [35] . We accordingly explored the involvement of Erk1 and Erk2 in TCR-induced shedding of CD62L. Downregulation of CD62L in antigen-stimulated P14 CD8 + T cells was blocked by the inhibitor PD184352 (Fig. 3a) , which prevents activation of the 'upstream' kinase MEK1 and, hence, Erk activation. The inhibition of PI(3)K and Erk kinases also blocked downregulation of CD62L in CD4 + and CD8 + T cells polyclonally activated with anti-CD3 ( Supplementary Fig. 2 online) . We also examined the function of Erk kinases in the transcriptional downregulation of CD62L that occurs in effector CTLs. Inhibition of Erk activation with PD184352 did not prevent CD62L downregulation in CTLs maintained with IL-2 ( Fig. 3b) . PI(3)K initiates signaling mediated by the mTOR (mammalian target of rapamycin) kinase, which is an evolutionarily conserved serine-threonine kinase that is central to the integration of signals from nutrients (amino acids) to regulate cell growth and proliferation 36 . We therefore assessed the effect of rapamycin, which inhibits the mTOR-raptor complex, on CD62L expression. TCR-induced downregulation of CD62L on primary CD8 + T cells was not blocked by rapamycin (Fig. 3c) . In contrast, downregulation of CD62L surface expression in CTLs was rapamycin sensitive. Treatment of CTLs with rapamycin prevented IL-2-induced downregulation of CD62L mRNA, and treated cells showed higher surface expression of CD62L (Fig. 3d,e) . Rapamycin did not globally change the expression of activation markers, as the expression of CD44 was unaffected by rapamycin treatment (Fig. 3f) . PI(3)K thus seems necessary for acute proteolytic cleavage of CD62L because of its involvement in regulating MAP kinases, whereas PI(3)K regulates CD62L transcription through mTOR.
The transcription factor KLF2 is a key modulator of the expression of homing receptors involved in the regulation of lymphocyte migration [37] [38] [39] . KLF2 directly regulates CD62L transcription by binding to the promoter of the gene encoding CD62L and is both necessary and sufficient for expression of CD62L 38, 39 . We therefore examined whether the sensitivity of transcription of the gene encoding CD62L to PI(3)K-mTOR inhibitors reflected involvement of these signals in controlling KLF2 expression. We did real-time PCR analysis of KLF2 mRNA in antigen-primed CD8 + T cells cultured in IL-15 or IL-2 (CTLs) and cultured in the presence or absence of LY294002 or rapamycin (Fig. 4a-c) . KLF2 mRNA was low in effector CTLs but was much higher in CTLs treated with the PI(3)K inhibitor LY294002 (Fig. 4b) . KLF2 mRNA expression was also higher in CTLs treated with rapamycin (Fig. 4c) . KLF2 expression in CTLs was thus negatively regulated by PI(3)K and mTOR. Activation of PI(3)K and mTOR induced loss of KLF2 and subsequently prevented the expression of KLF2 target genes such as that encoding CD62L. Another KLF2 gene target encodes sphingosine 1-phosphate receptor type 1 (S1P 1 ), which controls the egress of lymphocytes from secondary lymphoid organs [37] [38] [39] . IL-15-treated CD8 + T cells with lower PI(3)K signaling had more expression of S1P 1 mRNA than did IL-2-treated CD8 + T cells (Fig. 4d) . Moreover, treatment of IL-2-treated CD8 + T cells with the PI(3)K inhibitor LY294002 (Fig. 4e) or the mTOR inhibitor rapamycin (Fig. 4f) resulted in higher expression of the gene encoding S1P 1 (refs. 38,39) .
Loss of PTEN downregulates CD62L
The results reported above showed that PI(3)K signals were required for downregulation of CD62L but did not establish whether they were sufficient. PtdIns(3,4,5)P 3 is normally dephosphorylated by the 40 . Accordingly, to assess whether PtdIns(3,4,5)P 3 production was sufficient to downregulate CD62L, we assessed the surface phenotype of T cells after deletion of PTEN. In these experiments, we created mice with T cell-specific Pten deficiency ('PTEN-KO(T)' mice) by backcrossing mice with Pten alleles flanked by loxP-Cre recombinase excision sequences to Lck-Cre-transgenic mice that express Cre selectively in T cells 40 . CD62L expression was upregulated during thymus development, with the highest CD62L expression on CD4 + and CD8 + single-positive thymocytes (Fig. 5a) . Notably, CD62L expression in PTEN-KO(T) thymocytes was less than that in wild-type control cells. PTEN-KO(T) double-positive thymocytes thus had lower expression of CD62L than did wild-type double-positive cells (Fig. 5a) . PTEN-KO(T) single-positive cells were also CD62L lo (Fig. 5a ). We noted loss of CD62L in PTEN-null CD4 + and CD8 + single-positive thymocytes and peripheral T cells ( Fig. 5a and Supplementary Fig. 3 online) . The effect of PTEN loss on CD62L expression was mediated by changes in CD62L mRNA expression, which was lower in PTEN-KO(T) thymocytes than in wild-type thymocytes (Fig. 5b) . We noted no greater shedding of CD62L in PTEN-KO(T) thymocytes that might have accounted for the lower CD62L expression (Fig. 5c) . Instead, the loss of PTEN seemed to result in less shedding of CD62L in thymocytes. However, the failure of PTEN-KO(T) thymocytes to effectively produce CD62L mRNA and protein makes it impossible to reach any firm conclusion as to whether the greater production of PtdIns(3,4,5)P 3 as a result of PTEN deletion would be sufficient to directly regulate proteolytic cleavage of CD62L. (Fig. 5d) , reminiscent of the low expression of CD62L on T cells cultured in IL-2. Low expression of CD62L on the surfaces of CD8 + PTEN-KO(T) cells cultured in IL-15 was not due to more shedding of surface CD62L (Fig. 5e) ; instead, these changes in CD62L expression were reflected in the expression of CD62L mRNA, which was downregulated in PTEN-KO(T) T cells cultured in IL-15 ( Fig. 5f) .
antigen-primed PTEN-KO(T) cells cultured in IL-15 had low expression of CD62L
Consistent with the idea that KLF2 directly regulates expression of the gene encoding CD62L, the loss of CD62L in PTEN-KO(T) cells correlated with downregulation of KLF2 mRNA (Fig. 5g) . KLF2-deficient thymocytes have several defects in expression of T celltrafficking molecules, and one consequence of these defects is that mature T cells accumulate in KLF2-null thymi 39 . PTEN-KO(T) thymocyte samples had much a higher frequency of mature singlepositive cells (Fig. 5h) , as defined by low expression of CD24 (heatstable antigen), which indicated that PTEN deletion resulted in the retention of mature T cells in the thymus. Hence, activation of PI(3)K signaling immediately derails lymphocyte trafficking in vivo.
PI(3)K-mTOR signaling controls expression of CCR7
The chemokine receptor CCR7 is key for the coordinated migration of T cells into secondary lymphoid organs and also controls their motility and positioning in lymphoid tissues 12 . Immune activation of T cells results in downregulation of CCR7 expression, which is important for ensuing T cell immune responses. For example, downregulation of CCR7 during an antiviral immune response is important for virus clearance because it facilitates the release of effector CTLs from the splenic white pulp and promotes their migration to peripheral tissues 41 . KLF2 can regulate Ccr7 expression, and KLF2-deficient thymocytes simultaneously lose expression of CD62L and CCR7 (ref. 39) . Accordingly, the ability of PI(3)K and mTOR signaling pathways to downregulate KLF2 expression might also have consequences for CCR7 expression. To examine that possibility, we assessed CCR7 expression on antigen-primed CD8 + T cells cultured in IL-15 that had abundant expression of KLF2 and CD8 + T cells cultured in IL-2 that had much less expression of KLF2. Antigen-primed CD8 + T cells cultured in IL-2 downregulated CCR7 expression, whereas cells cultured in IL-15 remained CCR7 hi (Fig. 6a) . Notably, antigen-primed CD8 + T cells cultured with IL-2 in the presence of the PI(3)K inhibitor LY294002 failed to downregulate CCR7 (Fig. 6b) , which indicated that the loss of CCR7 in these cells was dependent on PI(3)K. Additional experiments showed the production of PtdIns(3,4,5)P 3 was sufficient to downregulate CCR7 expression. Hence, CCR7 expression was lost in CD8 + PTEN-KO(T) cells even when they were cultured with IL-15 (Fig. 6c) . We next examined the function of mTOR in regulating CCR7 expression. Antigen-primed CD8 + T cells cultured with IL-2 in the presence of the mTOR inhibitor rapamycin failed to downregulate CCR7 (Fig. 6d) . Notably, the CCR7 expressed on the T cells cultured in either rapamycin or LY294002 was functional (Fig. 6e) . Antigenprimed CD8 + T cells cultured in IL-2 lost the ability to move by chemotaxis in response to the CCR7 ligand CCL19, whereas cells treated with rapamycin or LY294002 retained that ability (Fig. 6e) .
The loss of CD62L and CCR7 by activated T cells is an important mechanism that prevents effector T cells from re-entering secondary lymphoid organs and facilitates their redirection to peripheral tissues. The ability of mTOR inhibitors to prevent loss of CD62L and CCR7 would allow immune-activated T cells to continue to traffic to secondary lymphoid tissues and hence 'dilute' their recruitment to peripheral tissues as required for these cells to exert their effector function. To test that hypothesis in vivo, we used adoptive transfer experiments to compare the ability of control effector CTLs or rapamycin-treated CTLs to home to secondary lymphoid tissues. In these experiments, we activated CD8 + P14 T cells for 2 d with gp33-41, followed by 2 d of culture in IL-2 in the presence or absence of rapamycin. We then labeled CD8 + T cells cultured with IL-2 alone or with IL-2 plus rapamycin with the cytosolic dye CFSE or the celltracking dye CMTMR, respectively, mixed them at a ratio of 1:1 and transferred them into C57BL/6 host mice. After 24 h, we analyzed host mouse tissues for the presence of the transferred cells. We noted salient differences in the in vivo trafficking of rapamycin-treated and control CTLs (Fig. 6f) . The rapamycin-treated cells retained the ability to home to secondary lymphoid organs and hence accumulated in lymph nodes and spleen. Thus, mTOR controls the trafficking patterns of effector CTLs.
DISCUSSION
In this study we have shown that PtdIns(3,4,5)P 3 and mTOR mediate antigen receptor-induced and cytokine-induced downregulation of CD62L and CCR7, two crucial molecules that regulate lymphocyte recirculation. Inhibition of PI(3)K prevented both the proteolytic cleavage pathways and transcriptional mechanisms that downmodulate CD62L expression in activated T cells. Higher cellular PtdIns(3,4,5)P 3 , obtained by deletion of PTEN, was sufficient to induce loss of expression of CD62L and CCR7 in thymocytes and effector T cells and immediately derailed lymphocyte trafficking in vivo. PI(3)K and mTOR were also essential for CCR7 downregulation by effector T cells. PtdIns(3,4,5)P 3 and mTOR are signaling molecules more usually associated with the control of T cell metabolism. In particular, mTOR has an evolutionary conserved function as a nutrient sensor and functions to match cell growth to a cell's metabolic capacity and nutrient availability. The ability of mTOR to control expression of CD62L and CCR7 and in vivo trafficking of T cells indicates that mechanisms have evolved to synchronize lymphocyte trafficking and nutrient availability and, hence, cellular energy status.
How important is the modulation of CD62L and CCR7 expression during T cell immune responses? It is well known that changes in cell surface expression of CD62L and CCR7 can substantially modify lymphocyte recirculation patterns and have a substantial effect on immune responses 15, 41, 42 . The transcriptional downregulation of CD62L during immune activation serves to prevent activated T cells from re-entering peripheral lymph nodes, thereby 'favoring' their migration to peripheral tissues. The acute downregulation of CD62L in T cells through endoproteolytic cleavage has biological relevance, as blocking CD62L cleavage on T cells perturbs their recirculation and inhibits antiviral T cell responses 21, 26, 43 . The loss of CCR7 expression by T cells after immune activation is just as important, as continued expression of CCR7 'favors' the retention of effector T cells in secondary lymphoid tissues rather than allowing their relocation to peripheral tissues where the cells exert effector function 41 .
There are many isoforms of PI(3)K, but here we have shown that the p110d catalytic subunit of PI(3)K is the important isoform for the regulation of CD62L in T cells. Studies have shown that the p110d isoform is predominant in TCR-PI(3)K signaling. Accordingly, the finding that p110d was the TCR-coupled PI(3)K that controlled CD62L expression was not unexpected, as loss of p110d prevents PtdIns(3,4,5)P 3 production in antigen-stimulated T cells 3 . It was unexpected, however, that IL-2 regulation of CD62L expression was dependent on p110d. Hence, although PI(3)K activity is essential for IL-2 signal transduction, T cells expressing p110d(D910A) grow and proliferate normally in response to IL-2. We therefore concluded that other PI(3)K isoforms such as p110a or p110g mediate IL-2 signal transduction. The finding that downregulation of CD62L expression by IL-2 was dependent on p110d affords the insight that the IL-2 receptor is coupled to many isoforms of PI(3)K that mediate distinct 'downstream' functions.
PtdIns(3,4,5)P 3 modulates the activity of several different signaltransduction pathways, including those mediated by MAP kinases and mTOR. A salient finding was that both of these PI(3)K-regulated signaling pathways control CD62L expression. We found that TCR-induced proteolytic cleavage of CD62L was dependent on TCR-PI(3)K-induced activation of Erk1 and Erk2, whereas a PI(3)K-mTOR pathway controlled expression of CD62L and CCR7 by regulating the cellular abundance of KLF2, a key transcription factor for CD62L and CCR7. The PI(3)K-mTOR-KLF2 pathway also controlled expression of S1P 1 , which controls the egress of lymphocytes from secondary lymphoid organs. The importance of MAP kinases in the regulation of transcription of genes encoding cytokines during T cell activation is known. Demonstration of the involvement of MAP kinases in regulating the proteolytic cleavage of CD62L provides the new insight that MAP kinases also control T cell trafficking. Similarly, the mTOR inhibitor rapamycin is used clinically as an immunosuppressant, but it has not been appreciated that regulation of lymphocyte trafficking might contribute to its clinical efficacy. It was originally thought that rapamycin suppressed immune responses because of the evolutionarily conserved function of mTOR kinases as nutrient sensors that regulate protein synthesis and cell cycle progression of T cells 5, 44 . It has subsequently been suggested that inhibition of mTOR promotes the generation of regulatory T cells that suppress immune responses 45, 46 . Our demonstration here that rapamycin prevented downregulation of the expression of CD62L, CCR7 and S1P 1 and controlled lymphocyte trafficking in vivo gives new insight into how rapamycin modulates immune responses. The ability of rapamycin to redirect activated effector T cells to secondary lymphoid organs could result in the destruction of antigen-primed dendritic cells and hence prematurely terminate immune responses 47 . The containment of activated cytotoxic T cells in secondary lymphoid organs would also prevent immune destruction of target cells in peripheral tissues. Moreover, secondary lymphoid organs provide the cytokine and stromal stimuli that promote T cell metabolism and survival. The use of common signaling pathways to control T cell metabolism and expression of lymph node-homing receptors would ensure that during immune responses, lymphocytes match metabolic competence to migration patterns.
METHODS
Mice and cells. Mice transgenic for the P14 lymphocytic choriomeningitis virus TCR 48 and C57BL/6 (wild-type) mice were bred and maintained at the University of Dundee in compliance with guidelines of UK Home Office Animals (Scientific Procedures) Act 1986. CD62L-null mice expressing transgenes encoding either wild-type cleavable CD62L under the control of the promoter of the human gene encoding CD2 or a noncleavable CD62L mutant have been described 26 . These mice have T lymphocyte-restricted expression of either wild-type CD62L or a noncleavable CD62L mutant generated by replacement of the membrane-proximal region of wild-type CD62L with the membrane-proximal region of P-selectin, which removes the proteolysis site of CD62L. Mice with a 'knock-in' substitution of PI(3)K wherein wild-type sequence of the p110d catalytic subunit of PI(3)K is replaced with sequence with a point substitution (D910A), which is a catalytically inactive form of p110d, have been described 29 . PTEN-KO(T)) mice were generated as described 40 by crossing of mice with loxP-flanked Pten alleles with mice expressing Cre recombinase under control of the proximal promoter of the gene encoding p56 lck .
For activation of primary T cells, spleens and/or lymph nodes were removed and disaggregated and red blood cells were lysed. Cells were cultured in RPMI-1640 medium containing L-glutamine (Invitrogen), 10% (vol/vol) heatinactivated FBS (Gibco), 50 mM b-mercaptoethanol (Sigma) and penicillinstreptomycin (Gibco). Single-cell suspensions from lymph node preparations or splenocytes were adjusted to a density of 2 Â 10 6 cells per ml or 5 Â 10 6 cells per ml, respectively. Cells from non-TCR-transgenic mice were stimulated with monoclonal anti-CD3 (5 mg/ml; 145-2C11; R&D Systems) to 'trigger' the TCR. Cells isolated from P14 mice were stimulated with soluble lymphocytic choriomeningitis virus-specific peptide gp33-41 (1 nM; KAVYNFATM; synthesized by the Cancer Research UK protein production laboratory). Where indicated, phorbol 12,13-dibutyrate (Calbiochem) was used at a final concentration of 20 ng/ml. Also where indicated, cells were incubated with specified kinase inhibitors. LY294002 (Promega) was used at a final concentration of 10 mM; rapamycin (Calbiochem) was used at a final concentration of 20 nM; and PD184352 (synthesized 'in-house' by the Division of Signal Transduction Therapy) was used at a final concentration of 2 mM. Cells were incubated at 37 1C with 5% CO 2 throughout. For the generation of lymphoblasts, mouse CD8 + T cells were grown from spleen or lymph node preparations cultured for 48 h in the presence of stimulus (monoclonal antibody 2C11 or peptide gp33-41), were washed and were resuspended at a density of 2 Â 10 5 cells per ml with IL-2 (Chiron) or IL-15 (Peprotech), each at a final concentration of 20 ng/ml. For the generation of lymphoblasts expressing p110d(D910A), splenocytes expressing p110d(D910A) were stimulated for 48 h with 2C11 (5 mg/ml) in the presence of IL-2 (20 ng/ml), then were washed and were resuspended at a density of 4 Â Flow cytometry. Fc receptors were blocked for 15 min at 4 1C with Fc Block (BD Pharmingen) in RPMI-1640 medium and 0.5% (vol/vol) FBS. Cells (100 ml at a density of 1 Â 10 7 to 2 Â 10 7 cells/ml) were then stained for 30 min at 4 1C with saturating concentrations of antibody in RPMI-1640 medium and 0.5% (vol/vol) FBS. Antibodies used were as follows: phycoerythrin-conjugated anti-CD62L (MEL-14), fluorescein isothiocyanate-conjugated anti-CD4 (L3T4; RM4-5), biotin-conjugated anti-TCRb (H57-597), phycoerythrin-conjugated anti-CD24 (M1/69), fluorescein isothiocyanate-conjugated anti-CD25 (3C7), phycoerythrin-conjugated anti-CD71 (C2F2) and phycoerythrin-indodicarbocyanine-conjugated anti-CD44 (IM7; all from BD Pharmingen); TriColoranti-CD8 (510) and streptavidin-allophycocyanin (both from Caltag); and phycoerythrin-conjugated anti-CD98 (RC388; eBiosciences). For CCR7 staining, cells were labeled with a fusion protein of mouse CCL19 and a human Fcg fragment and were detected with phycoerythrin-conjugated antihuman Fcg (12-4998; both from eBiosciences). For P-and E-selectin ligand staining, cells were labeled with recombinant P-selectin Fc and E-selectin Fc (R&D Systems) and were detected with allophycocyanin-conjugated antihuman Fcg (109-136-170; Jackson ImmunoResearch). Cells were washed and resuspended in RPMI-1640 medium and 0.5% (vol/vol) FBS before being acquired on a FACSCalibur or LSR (Becton Dickinson). A minimum of 1 Â 10 4 relevant events were collected and stored ungated; data were analyzed with FlowJo software (TreeStar). Live cells were gated according to their forward scatter and side scatter.
CD62L shedding assay. Cells were prepared at a density of 1 Â 10 6 to 2 Â 10 6 cells per ml in RPMI-1640 medium plus L-glutamine, 0.5% (vol/vol) heatinactivated FBS, 50 mM b-mercaptoethanol and penicillin-streptomycin. Cells in a volume of 100 ml were added in triplicate to wells for stimulation of the TCR or were incubated in the presence or absence LY294002 (10 mM). Cells were then incubated for 1 h at 37 1C in 5% CO 2 . Soluble CD62L in the supernatant was measured with the Mouse L-Selectin/CD62L DuoSet ELISA Development Systems kit (R&D Systems). The amount of soluble CD62L in the supernatant is presented as picograms of CD62L released per 1 Â 10 5 cells (pg/ 10 5 cells).
Quantitative real-time PCR. RNA was purified with the RNeasy RNA purification Mini Kit (Qiagen; genomic DNA was digested with RNase-free DNase (Qiagen) according to the manufacturer's instructions) and was reversetranscribed with the iScript cDNA synthesis kit (BioRad). Quantitative PCR was done on an iCycler (Bio-Rad) in 96-well plate format with iQ SYBR Green-based detection (Bio-Rad); 18S mRNA was used for normalization. Primers were as follows: 18S forward, 5¢-ATCAGATACCGTCGTAGTTCCG-3¢, and 18S reverse, 5¢-TCCGTCAATTCCTTTAAGTTTCAGC-3¢; CD62L forward, 5¢-ACGGGCCCCCGTGTCAGTATGTG-3¢, and CD62L reverse, 5¢-TGAGAA ATGCCAGCCCCGAGAA-3¢; KLF2 forward, 5¢-TGTGAGAAATGCCTTT GAGTTTACTG-3¢, KLF2 reverse, 5¢-CCCTTATAGAAATACAATCGGTCA TAGTC-3¢; and S1P 1 forward, 5¢-GTGTAGACCCAGAGTCCTGCG-3¢, and S1P 1 reverse, 5¢-AGCTTTTCCTTGGCTGGAGAG-3¢.
PtdIns(3,4,5)P 3 quantification. Intracellular concentration of PtdIns (3,4,5)P 3 in P14 CD8 + cells activated for 2 d with gp33-41 then maintained for 48 h with IL-15 or IL-2 were measured by time-resolved fluorescence resonance energy transfer displacement assay as described 49 .
CCL19 Transwell chemotaxis assay. Membrane inserts of Transwell chemotaxis plates (CoStar) were coated overnight at 4 1C with fibronectin (2 mg/ml; Sigma). Membranes were blocked for 1 h at 37 1C with 2% (vol/vol) heatinactivated FBS in PBS. Cells (5 Â 10 5 in 100 ml RPMI-1640 medium containing 0.5% (vol/vol) heat-inactivated FBS) were placed in the upper chamber of the Transwell plate in triplicate. CCL19 (600 ml, diluted to 200 ng/ ml; R&D Systems) was placed in the lower chamber, and the percent cells migrating across the membrane (5-mm pore size) was determined by flow cytometry after 3 h of incubation at 37 1C in 5% CO 2 .
Adoptive transfer. Mouse P14 CD8 + T cells were grown from spleen preparations cultured for 48 h in the presence of gp33-41, then were washed and were resuspended for 48 h at a density of 2 Â 10 5 cells per ml with IL-2 (final concentration, 20 ng/ml) in the presence or absence rapamycin (20 nM). CD8 + cells (50 Â 10 6 ) cultured with IL-2 alone were loaded with CellTracker Orange (CMTMR (5-(and-6)-(((4-chloromethyl)benzoyl) amino)tetramethylrhodamine); Invitrogen) and CD8 + cells (50 Â 10 6 ) cultured with IL-2 and rapamycin were loaded with CFSE (carboxyfluorescein diacetate succinimidyl diester; Invitrogen). Cells were mixed at a ratio of 1:1 and 10 Â 10 6 cells were injected into the tail veins of C57BL/6 mice. Then, 24 h later, recipient mice were killed, and blood, spleen and lymph nodes were removed for quantification of CMTMR-labeled and CFSE-labeled T cells by flow cytometry.
Additional methods. Information on immunoblot analysis and phospho-S6 ribosomal protein intracellular staining is available in the Supplementary Methods online.
Statistical analysis. GraphPad Prism 4.00 for Macintosh (GraphPad Software) was used for statistical analysis. The nonparametric Mann-Whitney test was used where the number of experiments was not sufficient to prove normal distribution. For comparison of KLF2 mRNA expression in CD8 + cells cultured with IL-2 and CD8 + cells cultured with IL-15, a one-sample t-test was used to calculate P values with the theoretical mean set to 1.00.
Accession codes. UCSD-Nature Signaling Gateway (http://www.signaling-gate way.org): A000094 and A001770.
Note: Supplementary information is available on the Nature Immunology website.
